11 – 20 of 31
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Krebs von den Lungen 6 (KL-6) is a novel diagnostic and prognostic biomarker in pleural mesothelioma
(
- Contribution to journal › Article
-
Mark
Dual targeting of BCL-2 and MCL-1 in the presence of BAX breaks venetoclax resistance in human small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Proteomic analysis of brain metastatic lung adenocarcinoma reveals intertumoral heterogeneity and specific alterations associated with the timing of brain metastases
(
- Contribution to journal › Article
-
Mark
Non-small cell lung cancer patients treated with Anti-PD1 immunotherapy show distinct microbial signatures and metabolic pathways according to progression-free survival and PD-L1 status
(
- Contribution to journal › Article
-
Mark
Laser ablation-inductively coupled plasma-mass spectrometry analysis reveals differences in chemotherapeutic drug distribution in surgically resected pleural mesothelioma
(
- Contribution to journal › Article
-
Mark
Comparative expression analysis of immune-related markers in surgically resected lung neuroendocrine neoplasms
(
- Contribution to journal › Article
-
Mark
Computed Tomography-Based Quantitative Texture Analysis and Gut Microbial Community Signatures Predict Survival in Non-Small Cell Lung Cancer
(
- Contribution to journal › Article
-
Mark
Thoracic irradiation as consolidation therapy in patients with extensive-stage small cell lung cancer
(
- Contribution to journal › Scientific review
- 2022
-
Mark
In-depth proteomic analysis reveals unique subtype-specific signatures in human small-cell lung cancer
(
- Contribution to journal › Article
-
Mark
Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small-cell lung cancer : an international multicenter study
(
- Contribution to journal › Article